Literature DB >> 27037337

Continuous Renal Replacement Therapy and Anticoagulation: What Are the Options?

Susan Dirkes1, Rob Wonnacott2.   

Abstract

Continuous renal replacement therapy is currently used as a standard treatment for acute kidney injury in the intensive care unit, particularly for patients with unstable hemodynamic status. Because this therapy is continuous, for days or weeks, and the extracorporeal blood circuit is large, the circuit is prone to clotting. Several methods of keeping the extracorporeal circuit patent are available, including heparin infusion, flushes with physiological saline, use of thrombin inhibitors, and citrate. This article reviews methods for continuous renal replacement therapy, anticoagulation, efficacy, and implications for bedside critical care. ©2016 American Association of Critical-Care Nurses.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27037337     DOI: 10.4037/ccn2016623

Source DB:  PubMed          Journal:  Crit Care Nurse        ISSN: 0279-5442            Impact factor:   1.708


  3 in total

1.  Regional Citrate Anticoagulation for Intermittent Hemodialysis in Dogs.

Authors:  T Francey; A Schweighauser
Journal:  J Vet Intern Med       Date:  2017-11-24       Impact factor: 3.333

2.  Treatment Effect of Regional Sodium Citrate Anticoagulation in Elderly Patients With High-Risk Bleeding Receiving Continuous Renal Replacement Therapy.

Authors:  Kang Xun; Hong Qiu; Miao Jia; Lihua Lin; Meiling He; Damei Li; Donghua Jin
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

3.  Artificial Liver and Renal Support System for Cynomolgus Monkeys with Surgery-Induced Acute Renal Failure: A Preclinical Study.

Authors:  Lei Feng; Guolin He; Lei Cai; Chaoyi Fu; Yang Li; Jun Weng; Xiaolin Huo; Qing Peng; Yi Gao
Journal:  Biomed Res Int       Date:  2018-05-24       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.